Background/Aims: Recent studies indicate that therapies targeting the vasculature can significantly sensitize tumors to radiation. Ultrasound-stimulated microbubbles (USMBs) are regarded as a promising radiosensitizer. In this study, we investigated the effect of USMBs on the sensitivity of nasopharyngeal carcinoma (NPC) to radiation. Methods: Human NPC (CNE-2) cells and human umbilical vein endothelial cells (HUVECs) were exposed to radiation (0, 2, and 8 Gy) alone or in combination with USMBs. Cell viability and apoptosis were measured with the MTT assay and flow cytometry, respectively. The angiogenic activity of HUVECs was detected using matrigel tubule formation. The in vitro effects induced by these treatments were confirmed in vivo with xenograft models of CNE-2 cells in nude mice by examining vascular integrity using color Doppler flow imaging and cell survival using immunohistochemistry. Additionally, the in vivo and in vitro expressions of angiotensin II (ANG II) and its receptor (AT1R) were detected by immunohistochemistry and western blotting, respectively. With CNE-2 cells and HUVECs transfected with control, ANG II, or AT1R, perindopril (an inhibitor of angiotensin-converting enzyme) and candesartan (an inhibitor of AT1R) were used to verify the role of ANG II and AT1R in the radiosensitivity of tumor and endothelial cells by USMBs, by determining cell viability and apoptosis and angiogenic activity. Results: In the NPC xenografts, USMBs slightly reduced blood flow and CD34 expression, increased tumor cell death and ANG II and AT1R expression, and significantly enhanced the effects of radiation. With CNE-2 cells and HUVECs, the USMBs further enhanced the inhibition of tumor cell viability and endothelial tubule formation and further enhanced the increase in ANG II and AT1R due to radiation. Furthermore, perindopril and candesartan significantly enhanced the 
Introduction
Nasopharyngeal carcinoma (NPC) is a type of head and neck malignant neoplasm with poor differentiation that is highly metastatic. In 2008, more than 84, 000 new cases of NPC were diagnosed worldwide and more than 50% of these cases died [1] . NPC occurs worldwide, but is geographically distributed to a higher extent within Southern China and Southeast Asia [2] . NPC derives from epithelial cells in the nasopharynx and can be classified into keratinizing squamous cell carcinoma, nonkeratinizing carcinoma, and undifferentiated carcinoma. The causes of NPC include genetic, viral, and dietary factors and their combinations [3] .
With many types of therapies for cancers, radiation remains the leading treatment for most NPC patients because of the unique anatomical location and moderate radiosensitivity of the tumor. In addition to the primary cell death induced by damaging cell DNA, destruction of the vasculature as a result of endothelial cell apoptosis leads to secondary large-scale tumor killing [4] . As blood vessels are critical for tumors, angiogenesis is promoted during tumor progression to ensure an abundant blood supply. Growing evidence indicates that death of the tumor-feeding vasculature is an important contributor to tumor killing and a primary determinant of overall response to radiotherapy [5, 6] . However, radiotherapy often fails in NPC, especially for advanced-stage tumors [7] , because resistance can be developed by tumors after radiotherapy. This can be achieved by enhancing DNA repair of cells and angiogenesis [8] .
The renin-angiotensin system (RAS) plays an important role in radiotherapy resistance. It is involved in various biophysiological processes, including blood pressure control, tissue remodeling, and angiogenesis. It was found that the dysregulation of RAS activity played an important role in modulating tumor biology, and this correlated with poor prognosis [9] . Angiotensin II (Ang II), a biologically active peptide, has a central role in the RAS. The biologic activity of Ang II is generated by binding to its receptors, type 1 (AT1R) and type 2 (AT2R). However, most of its functions, including radioresistance, are mediated by AT1R [10] . Retrospective studies with hypertensive patients indicated that angiotensin-converting enzyme inhibitors (ACEIs and AT1R blockers (ARBs) decreased the risk of developing some types of cancers [11, 12] . Furthermore, inhibition of tumor growth, angiogenesis, and metastasis by both ACEIs and ARBs was observed in mouse in vivo models [13, 14] .
To overcome radioresistance and increase survival, many attempts have been made to develop new radiosensitizers [15] [16] [17] [18] . Recent studies revealed that ultrasound-stimulated microbubbles (USMBs) induced vessel destruction in tumors [19] [20] [21] . Compared with antiangiogenic drugs, the microbubble provides ultrasound-guided local treatment to increase the probability of normal tissue sparing during treatment [22] . Recently, microbubbles have been used in cancer-treatment applications. It has been shown that the growth of colon cancer in mice was effectively inhibited by USMBs, which was achieved by blood vessel disruption and tumor tissue damage [23] . Based on the susceptibility of endothelial cells to microbubbles, it was confirmed that USMBs can significantly enhance the radiosensitivity of a variety of tumors, such prostate, bladder, and breast cancers [5, 24, 25] .
Microbubbles are gas-filled microspheres coated with lipid, protein, or biopolymer. They are frequently used in medical ultrasound applications, such as imaging, gene delivery, tumor ablation, and medical disruption. They have a median diameter of about 3 µm, so can circulate within the blood after peripheral intravenous injection [23] . When exposed Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
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Carcinoma to an appropriate ultrasound field, the encapsulating shell cracks, the encapsulated gas is released, and nonencapsulated bubbles are formed. This process is followed by the release of energy in various forms, such as thermal and shock waves, which mechanically perturb the surrounding tissue [25] .
In this study, USMBs were employed as an adjuvant to radiation. Using mouse NPC tumor models together with high-resolution power Doppler ultrasound, we found that USMBs significantly sensitized the vasculature to radiation, which resulted in endothelial cell death and subsequently tumor cell death. Based on the observation that ANG II and AT1R expression levels were significantly increased after treatment with USMBs or in combination with radiation, we demonstrated in this study, using an ACEI and an ARB, that ANG II and AT1R inhibition further induced cell growth inhibition and cell apoptosis by radiation in combination with USMBs. Thus, we provided evidence that concomitant treatment with USMBs alone or in combination with ANG II or AT1R inhibitors might significantly increase the efficacy of radiation treatment for NPC.
Materials and Methods

Cell culture and transfection
Human nasopharyngeal carcinoma cells (CNE-2) and human umbilical vein endothelial cells (HUVECs) were used in this study. The cell lines were obtained from American Type Culture Collection (Manassas, VA, USA), and were maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Gibco) and 100 U/mL penicillin/streptomycin at 37°C in a humid atmosphere containing 5% CO 2 . The cells were cultured to 80% confluence and harvested using 0.25% trypsin-ethylenediamine tetraacetic acid (EDTA) solution (Sigma-Aldrich, St. Louis, MO, USA) at room temperature. The plenti6/V5-DEST vector (Invitrogen, Carlsbad, CA, USA) was used to harbor ANG II or AT1R cDNA through cloning of cDNA sequences into the BamH I and Asc I sites. After amplification and DNA sequence confirmation, CNE-2 cells and HUVECs were stably transfected with the ANG II, AT1R, or control vector using Lipofectamine 2000 and grown in DMEM containing blasticidin.
Animals and tumor model
Female 4-week-old nude mice weighing 16 ± 1 g were purchased from Guangdong Experimental Animal Center (Foshan, China). They were housed in an animal facility at 24 ± 2°C with a relative humidity of 55 + 15%, with free access to food and water. After more than 1 week for acclimatization to the experimental conditions, mice were inoculated with 1 × 10 6 CNE-2 cells suspended in 100 µL matrigel into the lower right hind leg. Tumor formation in the mice was monitored twice weekly until a diameter of 5-8 mm was reached for experiments. All animal studies were conducted in accordance with the guidance of the Institutional Animal Care and Use Committee at Nanfang Hospital.
Microbubble preparation
We prepared the microbubbles according to the following method. In brief, microbubbles were composed of dipalmitoyl-phosphatidylcholine (Avanti Polar Lipids, Alabaster, AL, USA), dipalmitoyl phosphate (Avanti Polar Lipids), dipalmitoyl phosphoethanolamine glycol-5000 (Shearwater Polymers, Huntsville, AL, USA), glycerol, and propylene glycol dissolved in distilled water at an appropriate ratio. Next, perfluoropropane was infused into the solution, and the solution was shaken until a milky white color was formed. After being allowed to stand, the lower clear liquid was discarded and the microbubble solution was obtained (at a concentration of about 2.99 × 10 9 bubbles/ mL with a diameter of about 2.5 μm).
In vivo treatment
The tumor-bearing animals were divided into six groups (n = 8 per group) and received one of the following treatments: radiation alone (0, 2, or 8 Gy) and a combination treatment of USMBs followed by radiation. The experiments were performed as previously described [23, 26] . The microbubbles were injected into the tail vein at a concentration of 3% (v/v, according to the total mouse blood volume). The lower bodies of the mice were immersed into a water bath at 37°C for ultrasound exposure. Tumors were 
In vivo imaging
As previously described, blood flow was detected using color Doppler flow imaging by an Acuson Sequoia 512 system (Siemens, Mountain View, CA, USA) equipped with a 14L8 transducer. According to microbubble-specific contrast pulse sequencing technology, microvessel blood flow was detected with a low mechanical index of 0.08.
In vitro treatment CNE-2 cells received one of the following four treatments: (1) no treatment (control); (2) radiation alone (2 and 8 Gy); (3) USMBs alone; or (4) radiation plus USMBs. Further experiments were conducted with the transfected CNE-2 cells receiving one of the following three treatments: (1) radiation alone; (2) radiation plus USMB; or (3) a triple combination of ACEI/ARB, radiation, and USMB. About 8 × 10
5 cells were seeded in a 25-cm 2 flask approximately 1 day before ultrasound exposure. After adding 3% (v/v) microbubbles, cells immediately received ultrasound or sham treatment and were incubated for 24 h. Subsequently, cells were irradiated with a single dose of 2 or 8 Gy. For the triple treatment, ACEI/ARB was received at the same time as the microbbubles. Following these treatments, cells were used for western blotting and cell viability assays as described below.
Western blotting
Proteins were extracted from the tumor tissues and cells by lysing with RIPA buffer. Loading buffer with 20 μg cell protein or 50 μg tissue protein was used for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). After separation by SDS-PAGE, the proteins were transferred onto a nitrocellulose membrane and incubated with 5% nonfat milk in Tris-buffered saline +Tween 20 for about 1 h at room temperature. Then, protein bands were incubated with antibodies against ANG II, AT1R, and GAPDH (Sigma-Aldrich) at 4°C overnight. After washing 3 times with phosphate-buffered saline (PBS) + Tween 20, the samples were incubated with horseradish peroxidase-conjugated secondary antibody at room temperature for 1 h. Following the last washing, immunoreactive binding was detected with an electrochemiluminescence detection kit (Amersham, GE Healthcare, Little Chalfont, UK). GAPDH was used as the internal reference.
Cell viability
Cell proliferation was measured with the 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay (KeyGen, Nanjing, China). In brief, 2 × 10 3 CNE-2 cells were seeded in 96-well plates and grown in complete medium. At 24 h, 48 h, and 72 h after incubation, the medium was replaced with serum-free medium and MTT was added. After incubation for 4 h at 37°C, the medium containing MTT was removed and replaced with 150 μL DMSO. Then, the plates were gently rotated on a shaker for 10 min to completely dissolve the precipitate. Absorbance was measured at 490 nm using a microplate reader (BioRad, Hercules, CA, USA).
Flow cytometry
The cells for apoptosis analysis were detached with 0.25% EDTA-free trypsin and collected in centrifuge tubes. After centrifugation at 1000 rpm for 5 min, the medium was discarded and the cells were resuspended in pre-cooled PBS. Subsequently, cells were fixed in pre-cooled 70% ethanol and placed at 4°C overnight. After washing twice with PBS, the cells were stained with propidium iodide (KeyGen) for 30 min at 4°C in the dark. Data were collected using a BD FACSCalibur flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). 
Endothelial tube forming assay (in vitro angiogenesis)
Endothelial function was assessed by matrigel tubule formation assay as previously described [26] . About 2 × 10 6 /mL HUVECs received the same treatments as the CNE-2 cells. Combined treatments were performed by exposure to USMBs followed by irradiation within 2 min. The cells from each group were added in triplicate to the 96-well tissue culture plate coated with matrigel (Cell Biolabs, San Diego, CA, USA) and were incubated at 37°C with ACEI or ANG II inhibitor for about 18 h. The growth medium was gently removed, and formed tubular structures were evaluated.
Histopathology, immunohistochemistry, and TUNEL staining
After fixing in 10% neutral buffered formalin, the tumor tissues were spliced and partly dehydrated with ethanol and embedded in paraffin wax. Sections (5 μm thick) were prepared, dewaxed, and hydrated. Some of the samples were stained using hematoxylin and eosin (H&E) for histopathological evaluation.
Some of the sections were used for immunohistochemistry. In brief, samples were incubated at room temperature with 3% hydrogen peroxide for 5 min to block endogenous peroxidase, and then with normal goat serum for 30 min to reduce nonspecific binding. Then, the samples were incubated with anti-ANG II antibody and anti-AT1R antibody (abcam, Cambridge, UK) at 4°C overnight. Following incubation with biotinylated secondary antibody, the peroxidase reaction was developed with the DAB kit (Maixin Bio, Fuzhou, China). Finally, hematoxylin was used to counterstain nuclei. For a negative control, nonimmune serum was applied as the primary antibody.
In order to detect cell death, the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay was performed with a commercial kit (DeadEnd Colorimetric TUNEL System, Promega, Mannheim, Germany) using the peroxidase-inactivated sections, according to the manufacturer's protocol.
Statistical analysis
All data were analyzed with SPSS 21.0 (SPSS, Chicago, IL, USA). Data are expressed as the mean ± standard error of the mean. Data between two groups were compared using Student's t-test, and data within groups were tested using one-way analysis of variance. P < 0.05 was considered statistically significant.
Results
USMBs sensitized tumor cells and endothelial cells to radiation in vitro
To observe the effect of USMBs on the sensitivity of tumor cells to radiation, CNE-2 cells received the designated treatment and cell viability was examined at various timepoints. Firstly, we confirmed that treatment with USMBs or radiation alone significantly decreased the viability of the cells (Fig. 1A) . The inhibitory effect by radiation was increased in a timeand dose-dependent manner. Secondly, cell growth inhibition by radiation was enhanced by the USMBs. Based on these findings, apoptosis was examined by flow cytometry at 24 h after treatment. Consistent with the above results, apoptosis was significantly increased by either radiation or USMB treatment (Fig. 1B and 1C) . Furthermore, a synergetic effect on cell apoptosis of the two treatments was observed. All these results indicated that USMBs can induce cell growth inhibition and sensitize cells to radiation.
The effect of USMBs on endothelial cell function was assessed by matrigel tubule formation in vitro. Consistent with the observations for CNE-2 cells, angiogenic potential, as evidenced by decreased nodes and tubes, was inhibited by either radiation or USMB in comparison with the control (Fig. 1D) . Additionally, inhibition by radiation alone was doserelevant and was further enhanced by USMB treatment. These results confirmed that USMBs can directly inhibit the function of endothelial cells; the effects of radiation and USMBs were synergistic. Thus, treatment with USMBs might promote the destructive role of radiation in the vascular system.
USMBs sensitized tumor vasculature to radiotherapy
In order to confirm the effect of USMB treatment on the vasculature by radiotherapy in vivo, CNE-2 NPC cells were exposed to different levels of ionizing radiation with or without Fig. 2A , radiation significantly decreased blood flow dose dependently. Additionally, we observed that USMB treatment alone slightly decreased blood flow in tumors. Furthermore, the synergistic effect of USMBs was observed on the inhibitory role of radiation on blood flow at each dose. All these findings indicated that carcinoma microvessels were responsive to treatment with radiation and USMB, and the response to these treatments was synergistic.
To explore whether this reduction in blood flow was induced by a change in the morphology of the vasculature, the endothelial marker cluster of differentiation 34 (CD34) was detected by immunohistochemistry. As shown in Fig. 2B , both radiation and USMB reduced CD34 expression. The combination treatment further reduced the expression of CD34, indicating that USMBs promoted the reduced CD34 expression by radiation. As a marker of endothelial cells, the expression of CD34 was equivalent to the presence of endothelial cells, and was used to determine the structure of the vasculature. Analysis of CD34 expression revealed that the vessel numbers were significantly reduced after treatment with radiation or USMBs, and further reduced by their combined treatment. This indicated that the blood flow reduction resulted from endothelial damage and the consequent vessel lesion caused by radiation and enhanced by USMBs.
USMBs sensitized tumor cells to radiation in vivo
To observe whether the decrease in blood flow is correlated with tumor damage, tumor cell death was assessed by histopathology and TUNEL assay. As shown in Fig. 3A , treatment with radiation significantly induced tumor cell death, and this was most apparent at the highest dose (8 Gy). We observed that USMBs significantly induced cell death, and this significantly enhanced the damaging effect of radiation. Furthermore, there was apparent damage within the central region of the tumor, whereas less significant signs of cell death were observed within circumferential tumor regions. H&E staining confirmed these results (Fig. 3B) . Additionally, vessel damage was observed in the center, indicating that tumor cell death might occur around the blood vessels.
Effect of radiation and USMBs on the expression of ANGII and AT1R
Next, we investigated the expression of ANG II and AT1R in xenograft tumors. As shown in Fig. 4A , ANG II and AT1R were detectable in the xenograft tumors and their immunoreactivities were mainly observed in the cytoplasm and extracellular matrix of tumor cells. After radiation treatment, their expressions were increased in a dose-dependent Tumors comprise malignant cells, endothelial cells, immune cells, and others, and all these cells are associated with tumor pathogenesis and development. To observe whether radiation and USMBs affect the malignant cell directly, generation of ANG II and AT1R was measured by western blotting in CNE-2 cells and HUVECs. Consistent with the in vivo results, ANG II and AT1R were significantly increased after radiation treatment (Fig. 4B and 4C) ; these increases were further enhanced by USMB exposure. Together, our in vivo and in vitro results suggest that both radiation and USMBs can directly increase the expression of ANG II and AT1R in tumor and endothelial cells.
Effect of AT1R and ANG II inhibition on the radiosensitization by USMB
The RAS plays an important role in the hyperplasia and angiogenesis that underpin cell proliferation and malignancy. In this study, the effects of AT1R and ANG II on radiosensitization were investigated in transfected cells. Firstly, we examined the effects of the ACEI perindopril and the ARB candesartan on the growth of cells with control transfection. We found that perindopril and candesartan induced cytotoxicity in a dose-dependent manner without cell growth inhibition at maximal concentrations of 0.1 μM and 1 μM, respectively ( Fig. 5A and 5B). 
Carcinoma
To maximally reduce cytotoxicity, 0.1 μM perindopril and 1 μM candesartan were used in the following studies. The cell viability assay showed that cell growth inhibition by radiation alone or in combination with USMBs was significantly enhanced by the inhibitors, whereas inhibition was significantly blocked in the cells transfected with ANGII or AT1R (Fig. 5C ). Next cell apoptosis was determined by flow cytometry and endothelial function was determined by the tubule formation assay. It was noted that both cell apoptosis and inhibition of tubule formation were significantly increased after treatment with perindopril or candesartan, but significantly suppressed after ANGII and AT1R overexpression (Fig. 5D-5F ). This was consistent with the results of the cell viability assay described above.
Together, all our results indicate that both ANG II and AT1R inhibition significantly sensitized the tumor and endothelial cells to radiation alone or combined radiation with USMBs. 
Discussion
In this study, we observed the effects on the NPC tumor model of USMBs and radiation using histopathology and high-frequency Doppler ultrasound. This was the first time that direct evidence has been provided to show that USMBs can enhance the response to radiation in a model of NPC. An ACEI and an AT1R antagonist were used to test whether the effect of radiation and USMBs can be further enhanced. The additive effect on radiation treatment or in combination with USMBs was observed in vitro.
Radiation is one of the most effective treatments for some types of cancer, such as NPC and brain tumor, due to its excellent local control and increased overall survival rates [27] . Consistent with the reported efficacy in NPC, tumor cell death was significantly induced by radiation in this study. Despite the wide use and well-recognized efficacy of radiotherapy, resistance to radiation can be acquired by the surviving cells. Following radiation-induced damage of cells in tumors, many survival pathways are activated to protect cells from death. These pathways not only directly promote cell survival by increasing proliferation, invasion, and anti-apoptosis, but also contribute to improve the microenvironment, such as through angiogenesis [28] [29] [30] [31] . Similarly, NPC can acquire resistance to radiation through antiapoptotic pathways by increasing DNA damage repair and through facilitating angiogenesis by enhancing ANG II. In this study, we found that ANG II and AT1R were significantly increased in the tumor xenografts. ANG II has been shown to be pro-angiogenic through several potential mechanisms mainly via AT1R, including increasing expression of key growth factors, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor, and increasing the production of matrix metalloproteinases to modulate new vessel formation [32] .
To improve the efficacy of radiotherapy against tumors and overcome resistance, it is used in combination with cytotoxic drugs or cancer therapy targeting the vasculature. However, the use of cytotoxic drugs results in a range of adverse effects, commonly including hyperuricemia, bone marrow suppression, oral mucositis, gastrointestinal discomfort, and alopecia. Additionally, there are specific adverse effects associated with targeted cancer therapy, such as hematological and cardiovascular changes with VEGF antibody. With radiotherapy, a variable period of treatment with cytotoxic or targeting drugs is likely to induce resistance due to genetic heterogeneity and instability in tumors. With regard to local responses, it has been suggested that USMBs are an adjuvant therapy that can enhance the antitumor effectiveness of chemotherapy and radiotherapy. In this study, we observed that adjuvant USMB treatment had an additive effect on radiotherapy, which was demonstrated by a significant increase in tumor cell death and vascular destruction.
It is well recognized that the major mechanism by which USMBs induce cell death is associated with mechanical perturbation of the surrounding tissues and the dysregulated mediators of cell apoptosis. During microbubble oscillation and cavitation, the surrounding cells can be damaged and the adjacent microvessels can even become ruptured. Following these mechanical changes, a range of biological effects on surrounding cells can be induced at physiological and tissue levels due to released energy. These biological effects include gene expression changes, as well as cell death and vascular shutdown [5, 33] . Consistently, slightly increased vascular shutdown and tumor cell death were observed after USMB treatment in this study. Tumor cell death was linked to the biophysical damage of tumor endothelial cells due to USMB stimulation, subsequently leading to ceramide signaling and vascular shutdown due to endothelial cell death [34] . Additionally, tumor cell injury and lysis were directly induced by USMBs. This might be due to the extravasation of microbubbles into tumor tissues, based on the observations that microvessels ruptured on a microsecond time scale after oscillation resulting in the leakage of red blood cells [25] .
The synergistic effect of USMBs on radiation therapy varies depending on the ultrasound frequency and the interval between USMB therapy and radiation treatment. The lower the ultrasonic frequency, the stronger the ultrasonic cavitation effect will be. A previous study showed that an ultrasound frequency of 238 kHz can efficiently hinder the growth of tumors [23] . Furthermore, it was suggested that treatment effects were optimal when USMBs and radiation were delivered within 6 h of each other [26] . Employing the above methods produced the expected results, although the microbubbles used in this study were prepared differently from those used in other studies; here, they were prepared with distilled water instead of PBS to dissolve phospholipids. The difference in biological effect induced by the various methods of production needs to be examined in further studies. The resistance of tumors to therapy is associated with the level of ANG II. In this study, the protein and its receptor, AT1R, were significantly induced in vivo after USMB treatment, while USMBs significantly enhanced the effectiveness of radiotherapy. The expression of ANG II and AT1R can be significantly induced by hypoxia-inducible factor 1-alpha. Therefore, the vascular shutdown following endothelial cell damage and apoptosis might contribute importantly to the increased expression of ANG II and AT1R. Using CNE-2 cells, we confirmed for the first time that ANG II and AT1R in NPC cells are directly increased by radiation and USMBs. However, the underlying mechanisms need further investigation. Nevertheless, we observed that inhibiting AT1R and ANG II can significantly enhanced CNE-2 inhibition by radiation alone or in combination with USMBs.
Conclusion
USMBs are an attractive vascular targeting agent that can improve the effects of radiation on NPC tumors. This might be achieved by a synergistic effect on endothelial and tumor cell disruption. Radiotherapy fails in a considerable number of cases, and our results suggest that populations with radioresistance may have a higher sensitivity to radiation in combination with USMBs. Furthermore, our observations provide new insights into the clinical significance of using ANG II and AT1R inhibition together with radiation and USMBs.
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